Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Suzhou Basecare Medical Corp. Ltd. Class H ( (HK:2170) ).
Suzhou Basecare Medical Corp. Ltd. announced the poll results of its 2024 Annual General Meeting and the 2025 First Class Meetings for various shareholders. While most resolutions were passed, a resolution at the H Shareholders Class Meeting was not approved. The meetings were conducted in compliance with relevant laws and regulations, and the results are considered lawful and valid. This announcement reflects the company’s ongoing governance processes and may impact its shareholder relations and strategic decisions moving forward.
More about Suzhou Basecare Medical Corp. Ltd. Class H
Suzhou Basecare Medical Corp. Ltd. is a company based in the People’s Republic of China, operating in the medical industry. The company is involved in providing medical products and services, with a focus on genetic testing and related healthcare solutions.
Average Trading Volume: 123,008
Technical Sentiment Signal: Sell
Current Market Cap: HK$738.5M
Learn more about 2170 stock on TipRanks’ Stock Analysis page.